ANG Lifesciences India's board is all set to invest in the Equity Shares and Redeemable Cumulative Preference Shares of Baddi Agro. Consequent to the acquisition of 51% Equity stake by the company, Baddi Agro will become the subsidiary company of ANG Lifesciences India. The object of the said acquisition is to expand its business activities for manufacturing of Menthol API Derivative and other related products. The company's Board of Directors in their meeting held on November 8, 2021 had decided the same.
ANG Lifesciences India, incorporated in the year 2006, started with the business of manufacturing and marketing of finished pharmaceutical formulation in a dosage form of Sterile Dry Powder Injection Vial.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1872.50 |
| Dr. Reddys Lab | 1294.15 |
| Cipla | 1321.15 |
| Zydus Lifesciences | 948.00 |
| Lupin | 2275.80 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: